BYAMPI Trademark

Trademark Overview

On Monday, July 14, 2014, a trademark application was filed for BYAMPI with the United States Patent and Trademark Office. The USPTO has given the BYAMPI trademark a serial number of 86336368. The federal status of this trademark filing is CANCELLED - SECTION 18 as of Monday, November 1, 2021. This trademark is owned by AstraZeneca AB. The BYAMPI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, and nervous system diseases and disorders
byampi

General Information

Serial Number86336368
Word MarkBYAMPI
Filing DateMonday, July 14, 2014
Status713 - CANCELLED - SECTION 18
Status DateMonday, November 1, 2021
Registration Number4879400
Registration DateTuesday, January 5, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, and nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateMonday, November 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Monday, November 1, 2021CANCELLED SECTION 18-TOTAL
Monday, November 1, 2021CANCELLATION TERMINATED NO. 999999
Wednesday, August 4, 2021CANCELLATION GRANTED NO. 999999
Monday, May 17, 2021CANCELLATION INSTITUTED NO. 999999
Tuesday, January 5, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 5, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, December 2, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, October 22, 2015NOTICE OF ALLOWANCE CANCELLED
Wednesday, November 25, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 22, 2015TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, May 26, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 31, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 17, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 17, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 17, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 16, 2015ASSIGNED TO LIE
Monday, February 9, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 9, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 9, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 25, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 25, 2014NON-FINAL ACTION E-MAILED
Monday, August 25, 2014NON-FINAL ACTION WRITTEN
Tuesday, August 19, 2014ASSIGNED TO EXAMINER
Friday, July 18, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 17, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

byampi diseases disorders substances preparations pharmaceutical infection gastrointestinal system nervous inflammation